Who owns Kymera Therapeutics, Inc.?
Institutional ownership of KYMR from SEC Form 13F filings across 182 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
182
13F holders
$5.28B
value, 2026 filers
65%
of shares outstanding (53.5M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of KYMR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.3M | $1.42B | 0.1% | 15% | +5.5% |
| 2 | PRICE T ROWE ASSOCIATES INC /MD/ | 7.1M | $815,646 | 0.1% | 8.6% | +17.4% |
| 3 | BlackRock, Inc. | 5.5M | $635.1M | 0.0% | 6.7% | +9.4% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 3.7M | $421.4M | 0.1% | 4.5% | -5.5% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.0M | $343.1M | 0.0% | 3.6% | +4.1% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $336.3M | 0.0% | 3.6% | -49.1% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $208.3M | 0.0% | 2.2% | +10.4% |
| 8 | Capital Research Global Investors | 1.4M | $159.3M | 0.0% | 1.7% | -17.0% |
| 9 | GOLDMAN SACHS GROUP INC | 1.2M | $136.2M | 0.0% | 1.4% | +33.6% |
| 10 | UBS Group AG | 1.0M | $115.6M | 0.0% | 1.2% | -1.6% |
| 11 | ALLIANCEBERNSTEIN L.P. | 981,521 | $81.8M | 0.0% | 1.2% | +10.5% |
| 12 | NORGES BANKNEW | 757,246 | $86.8M | 0.0% | 0.9% | new |
| 13 | FEDERATED HERMES, INC. | 749,398 | $85.9M | 0.1% | 0.9% | +39.6% |
| 14 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 736,866 | $84.5M | 0.0% | 0.9% | -15.9% |
| 15 | NORTHERN TRUST CORP | 581,907 | $66.7M | 0.0% | 0.7% | +17.7% |
| 16 | Sixth Street Partners Management Company, L.P.NEW | 529,729 | $60.7M | 10.5% | 0.6% | new |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 529,729 | $60.7M | 0.0% | 0.6% | +7.0% |
| 18 | FRANKLIN RESOURCES INC | 515,050 | $59.1M | 0.0% | 0.6% | +42.4% |
| 19 | JENNISON ASSOCIATES LLC | 502,978 | $57.7M | 0.0% | 0.6% | -1.2% |
| 20 | Woodline Partners LP | 500,868 | $57.4M | 0.2% | 0.6% | +23.0% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 449,731 | $51.6M | 0.0% | 0.5% | +5.2% |
| 22 | Pictet Asset Management Holding SA | 395,540 | $45.0M | 0.0% | 0.5% | -15.6% |
| 23 | BANK OF AMERICA CORP /DE/ | 378,286 | $43.4M | 0.0% | 0.5% | +30.7% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 375,868 | $43.1M | 0.0% | 0.5% | +31.5% |
| 25 | TWO SIGMA INVESTMENTS, LP | 371,374 | $42.6M | 0.0% | 0.5% | +44.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.